Matches in Wikidata for { <http://www.wikidata.org/entity/Q92165468> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q92165468 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q92165468 description "scientific article published on 21 May 2019" @default.
- Q92165468 description "wetenschappelijk artikel" @default.
- Q92165468 description "наукова стаття, опублікована 21 травня 2019" @default.
- Q92165468 name "Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study" @default.
- Q92165468 name "Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study" @default.
- Q92165468 type Item @default.
- Q92165468 label "Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study" @default.
- Q92165468 label "Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study" @default.
- Q92165468 prefLabel "Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study" @default.
- Q92165468 prefLabel "Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study" @default.
- Q92165468 P1433 Q92165468-3D1B03B2-F3AB-425D-8A4F-999A1099DF13 @default.
- Q92165468 P1476 Q92165468-38CCF7C1-69FB-4F11-99D6-41AC2218D10F @default.
- Q92165468 P2093 Q92165468-0479B22D-03AB-453B-A3E4-A62F4F4480E8 @default.
- Q92165468 P2093 Q92165468-06F6C3B6-BD75-461D-B03B-34D0F8918DE3 @default.
- Q92165468 P2093 Q92165468-14960C5D-91D1-4919-97A1-E46CCE111022 @default.
- Q92165468 P2093 Q92165468-1B72A3B9-EFFB-4195-8BE1-1D18D3CC5ABE @default.
- Q92165468 P2093 Q92165468-223634E4-4DEB-4C81-87CA-85C9805F7928 @default.
- Q92165468 P2093 Q92165468-246DF90D-2DE9-4FBD-9C3B-4692823D42ED @default.
- Q92165468 P2093 Q92165468-424CD539-26DD-4674-A428-6AFB595DCA0F @default.
- Q92165468 P2093 Q92165468-49FC6EEB-761A-48BD-9C02-DD087BFEA702 @default.
- Q92165468 P2093 Q92165468-52934E56-FF36-4EFD-8CE0-5F8B95E47963 @default.
- Q92165468 P2093 Q92165468-6B0F77AD-C776-4B02-9F8A-EC1FCA6DA2C6 @default.
- Q92165468 P2093 Q92165468-88AC1B31-E57E-4B65-A9E1-E6FDC870C9D1 @default.
- Q92165468 P2093 Q92165468-BB176392-91D2-4811-BEBA-106B5E6DE0DA @default.
- Q92165468 P2093 Q92165468-BFA32E0A-D7F2-4D00-BA4C-D1FA349FCCD3 @default.
- Q92165468 P2093 Q92165468-F680897D-A8E1-40EC-B0C1-11F6EA7DE36F @default.
- Q92165468 P2860 Q92165468-50427D15-1533-4323-90CF-5FAB3B99BAB2 @default.
- Q92165468 P304 Q92165468-03998DDF-13DA-44C4-B2D9-375DC5896E16 @default.
- Q92165468 P31 Q92165468-771FD4B0-57BB-4C17-BD31-6E89AA7A7CFD @default.
- Q92165468 P356 Q92165468-56418767-808C-4586-8177-4C3DD60D0773 @default.
- Q92165468 P433 Q92165468-7FD2EC5A-6495-4414-847F-9B03E5525328 @default.
- Q92165468 P478 Q92165468-C8674C31-5B94-4E5F-B08D-0A49081C04BD @default.
- Q92165468 P50 Q92165468-19E324F8-75CC-465C-9B5C-B3AED45E1237 @default.
- Q92165468 P50 Q92165468-C223855C-7881-4577-863D-C07B7F96EEEA @default.
- Q92165468 P577 Q92165468-F4E13B84-5F72-4BE1-9DED-EFBD6565A654 @default.
- Q92165468 P698 Q92165468-D82D1F2B-07B8-4461-8E0F-B5783FEFC7C5 @default.
- Q92165468 P921 Q92165468-470960D5-28F2-4675-BEAE-D9890B02E9DB @default.
- Q92165468 P356 APPI.AJP.2019.19020172 @default.
- Q92165468 P698 31109201 @default.
- Q92165468 P1433 Q1935368 @default.
- Q92165468 P1476 "Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study" @default.
- Q92165468 P2093 "Christine Mazzucco" @default.
- Q92165468 P2093 "David Hough" @default.
- Q92165468 P2093 "Ella J Daly" @default.
- Q92165468 P2093 "Husseini Manji" @default.
- Q92165468 P2093 "Jaskaran B Singh" @default.
- Q92165468 P2093 "Kimberly Cooper" @default.
- Q92165468 P2093 "Madhukar Trivedi" @default.
- Q92165468 P2093 "Malek Bajbouj" @default.
- Q92165468 P2093 "Michael E Thase" @default.
- Q92165468 P2093 "Pilar Lim" @default.
- Q92165468 P2093 "Richard C Shelton" @default.
- Q92165468 P2093 "Rosanne Lane" @default.
- Q92165468 P2093 "Vanina Popova" @default.
- Q92165468 P2093 "Wayne C Drevets" @default.
- Q92165468 P2860 Q34529333 @default.
- Q92165468 P304 "428-438" @default.
- Q92165468 P31 Q13442814 @default.
- Q92165468 P356 "10.1176/APPI.AJP.2019.19020172" @default.
- Q92165468 P433 "6" @default.
- Q92165468 P478 "176" @default.
- Q92165468 P50 Q20090640 @default.
- Q92165468 P50 Q57228246 @default.
- Q92165468 P577 "2019-05-21T00:00:00Z" @default.
- Q92165468 P698 "31109201" @default.
- Q92165468 P921 Q7836891 @default.